Evidence map›Paper›PMID 33635468›Full record

GuidelineClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2021

SEOM clinical guidelines for the treatment of head and neck cancer (2020).

R Mesia, L Iglesias, J Lambea, J Martínez-Trufero, A Soria, M Taberna, J Trigo, M Chaves, A García-Castaño, J Cruz

Erratum issuedOpen access · hybridAbstract readPractice Guideline
In one paragraph

Guideline in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 57 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 4 pooled it
13.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 4 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Incidence of osteoradionecrosis after dental extractions in head and neck cancer patients: a retrospective cohort study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  13. Article
  14. Prognostic value of pretreatment peripheral blood biomarkers in patients with head and neck squamous cell carcinoma treated with chemo/bioradiotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  15. Assessing oral and dental health-related quality of life in head and neck cancer patients at 1, 5, and 10 years: a comparison of the EORTC QLQ43, FACT H&N, and the Orthognathic-QLQ questionnaires.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 1 country.

R MesiaInstitut Català d'Oncologia, Badalona, Spain. rmesia@iconcologia.net.ORCID http://orcid.org/0000-0002-3785-3563
L IglesiasServicio de Oncología Médica, Hospital Universitario 12 de Octubre, 12 de Octubre, Madrid, Spain.
J LambeaServicio de Oncología Médica, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
J Martínez-TruferoServicio de Oncología Médica, Hospital Universitario Miguel Servet, Zaragoza, Spain.
A SoriaServicio de Oncología Médica, Hospital Universitario Ramón y Cajal, Madrid, Spain.
M TabernaInstitut Català d'Oncologia, Hospitalet de Llobregat, Spain.
J TrigoServicio de Oncología Médica, Hospital Clínico Virgen de la Victoria, Málaga, Spain.
M ChavesServicio de Oncología Médica, Hospital Virgen de Valme, Seville, Spain.
A García-CastañoServicio de Oncología Médica, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
J CruzServicio de Oncología Médica, Hospital Clínico Universitario de Salamanca, Salamanca, Spain.
Institut Català d'Oncologia · ESComplejo Hospitalario de Salamanca · ESHospital Clínico Universitario Lozano Blesa · ESHospital Clínico Universitario Virgen de la Victoria · ESHospital Universitario 12 De Octubre · ESHospital Universitario Miguel Servet · ESHospital Universitario Ramón y Cajal · ESHospital Virgen del Valle · ESMarqués de Valdecilla University Hospital · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Head and neck cancers (HNC) are defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence obtained since 2017 publication, the Spanish Society of Medical Oncology (SEOM) presents an update of the squamous cell HNC diagnosis and treatment guideline. Most relevant diagnostic and therapeutic changes from the last guideline have been updated: introduction of sentinel node biopsy in early oral/oropharyngeal cancer treated with surgery, concomitant radiotherapy with weekly cisplatin 40 mg/m

Indexed as

AlphapapillomavirusChemoradiotherapy, AdjuvantCisplatinHead and Neck NeoplasmsHumansImmune Checkpoint InhibitorsMedical OncologyMouth NeoplasmsNeoplasm StagingOrgan Sparing TreatmentsOropharyngeal NeoplasmsRadiation-Sensitizing AgentsRadiotherapy, AdjuvantSentinel Lymph Node BiopsySocieties, MedicalSpainCisplatinImmune Checkpoint InhibitorsRadiation-Sensitizing AgentsChemoradiotherapyHead and neck cancerHuman papillomavirusImmunotherapy

Identifiers

PMID33635468
PMCPMC8057973
OpenAlexW3132560673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.